Trial Outcomes & Findings for A Clinical Trial to Evaluate the Safety and Effectiveness of the Raindrop Near Vision Inlay for Pseudophakic Subjects (NCT NCT03017612)
NCT ID: NCT03017612
Last Updated: 2018-03-01
Results Overview
75% of implanted eyes should achieve uncorrected near visual acuity (40cm/16in) of 20/40 or better
TERMINATED
NA
13 participants
12 months postoperatively
2018-03-01
Participant Flow
Participant milestones
| Measure |
Single Arm Study
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Overall Study
STARTED
|
13
|
|
Overall Study
COMPLETED
|
11
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
Single Arm Study
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Overall Study
Adverse Event
|
2
|
Baseline Characteristics
A Clinical Trial to Evaluate the Safety and Effectiveness of the Raindrop Near Vision Inlay for Pseudophakic Subjects
Baseline characteristics by cohort
| Measure |
Single Arm Study
n=13 Participants
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
5 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
8 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Caucasian
|
10 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
African American
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
0 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
2 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
13 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 12 months postoperatively75% of implanted eyes should achieve uncorrected near visual acuity (40cm/16in) of 20/40 or better
Outcome measures
| Measure |
Single Arm Study
n=13 Participants
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Percentage of Implanted Eyes With Improvement in Uncorrected Near Vision
|
100 Percentage of Implanted Eyes
|
SECONDARY outcome
Timeframe: at 6 months postoperatively and all subsequent time points up to 24 monthsFewer than 5% of eyes should lose two lines or more of best corrected distance and near visual acuity and less than 1% of eyes with preoperative best corrected visual acuity (BCVA) of 20/20 should have best corrected distance and near visual acuity worse than 20/40
Outcome measures
| Measure |
Single Arm Study
n=12 Participants
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Preservation of Best Corrected Visual Acuity
|
92 Percentage of Implanted Eyes
|
SECONDARY outcome
Timeframe: At 6 months postoperatively and all subsequent time points up to 24 monthsFewer than 5% of eyes should have postoperative manifest refractive astigmatism that increases from baseline by greater than 2.00 D
Outcome measures
| Measure |
Single Arm Study
n=13 Participants
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Percentage of Implanted Eyes With a Postoperative Manifest Refraction Astigmatism That Increased From Baseline by Greater Than 2.00 D
|
0 Percentage of Implanted Eyes
|
SECONDARY outcome
Timeframe: During the length of the study, up to 24 monthsAny specific adverse event should occur in less than or equal to 5% of eyes.
Outcome measures
| Measure |
Single Arm Study
n=13 Participants
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Occurrence of Adverse Events
Intraocular Pressure increase
|
2 Occurrence of specific adverse events
|
|
Occurrence of Adverse Events
Inlay Explant
|
2 Occurrence of specific adverse events
|
|
Occurrence of Adverse Events
Diffuse Lamellar Keratitis
|
1 Occurrence of specific adverse events
|
|
Occurrence of Adverse Events
Loss of BCVA due to late onset of haze
|
1 Occurrence of specific adverse events
|
|
Occurrence of Adverse Events
Hospitalization
|
1 Occurrence of specific adverse events
|
|
Occurrence of Adverse Events
Epiretinal Membrane
|
1 Occurrence of specific adverse events
|
SECONDARY outcome
Timeframe: at 12 months postoperatively75% of eyes should achieve uncorrected intermediate visual acuity (80 cm/32 in) of 20/40 or better
Outcome measures
| Measure |
Single Arm Study
n=12 Participants
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Uncorrected Intermediate Visual Acuity
|
92 Percentage of Implanted Eyes
|
Adverse Events
Single Arm Study
Serious adverse events
| Measure |
Single Arm Study
n=13 participants at risk
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Hospitalization due to triple arthrodesis surgery (secondary to muscular dystrophy)
|
7.7%
1/13 • Number of events 1 • 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months
|
Other adverse events
| Measure |
Single Arm Study
n=13 participants at risk
Evaluating the safety and effectiveness of the raindrop near vision inlay implanted in bilateral pseudophakic subjects
Raindrop Near Vision Inlay: A single-arm study to evaluate the effectiveness of a 2 mm corneal inlay (Raindrop Near Vision Inlay) for the treatment of presbyopia (age-related near vision loss). The anterior curvature of the cornea is re-shaped after implanting the Raindrop Near Vision Inlay in the non-dominant eye under a femtosecond laser flap to improve near and intermediate vision.
|
|---|---|
|
Eye disorders
Increase in intraocular pressure > 10mmHg above baseline
|
15.4%
2/13 • Number of events 2 • 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months
|
|
Eye disorders
Inlay explant
|
15.4%
2/13 • Number of events 2 • 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months
|
|
Eye disorders
Diffuse Lamellar Keratitis (DLK)
|
7.7%
1/13 • Number of events 1 • 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months
|
|
Eye disorders
Loss of BCVA due to late onset of haze
|
7.7%
1/13 • Number of events 1 • 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months
|
|
Eye disorders
Epiretinal Membrane
|
7.7%
1/13 • Number of events 1 • 1 day, 1 week, 1 month, 3 months, 6 months, 9 months, 12 months
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee The investigator agreed to hold this information in confidence and not to disclose it to any third parties for a period of three years from the date of this agreement, or until this information becomes a matter of public knowledge or until a formal agreement for that purpose has been entered into by the parties.
- Publication restrictions are in place
Restriction type: OTHER